Abstract | BACKGROUND: In nonhypertensive individuals, lower levels of 25-hydroxyvitamin D (25[ OH]D) have been associated with an increased risk of hypertension, and vitamin D deficiency has been associated with endothelial dysfunction in such individuals. However, the effect of vitamin D supplementation on endothelial dysfunction in nonhypertensive individuals has not been examined in a rigorous fashion. METHODS: In this randomized, double-blind, placebo-controlled trial of nonhypertensive, nondiabetic overweight, or obese individuals with vitamin D deficiency (body mass index ≥25 and 25[ OH]D ≤ 20 ng/ml), we assigned subjects to receive either ergocalciferol (50,000 units) or matching placebo, once a week for 8 weeks. Our primary outcome was endothelial-dependent vasodilation (EDV) measured by brachial artery ultrasound at baseline and 8 weeks postrandomization. RESULTS: By the end of the trial, 46 and 47 participants were allocated to receive ergocalciferol and placebo, respectively. Mean 25( OH)D levels increased from 14.9 to 30.3 in the vitamin D group and 14.4 to 17.4 in the placebo. EDV did not change significantly with either vitamin D repletion (from 6.3 ± 3.6% at baseline to 6.1 ± 4.6% at 8 weeks; P value = 0.78) or placebo (7.9 ± 4.7% to 6.8 ± 4.7%; P = 0.17). The treatment effect P value (comparing the 8-week change with ergocalciferol to the change with placebo) was 0.35. CONCLUSIONS: In this randomized, double-blind, placebo-controlled trial, there was no improvement in endothelial function (measured as EDV) after repletion of vitamin D in overweight/obese nonhypertensive individuals.
|
Authors | Lea Borgi, Ciaran McMullan, Ann Wohlhueter, Gary C Curhan, Naomi D Fisher, John P Forman |
Journal | American journal of hypertension
(Am J Hypertens)
Vol. 30
Issue 2
Pg. 124-129
(Feb 2017)
ISSN: 1941-7225 [Electronic] United States |
PMID | 28077419
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Copyright | © American Journal of Hypertension, Ltd 2016. All rights reserved. For Permissions, please email: [email protected]. |
Chemical References |
- Vitamins
- Vitamin D
- 25-hydroxyvitamin D
|
Topics |
- Administration, Oral
- Adult
- Brachial Artery
(diagnostic imaging, drug effects, physiopathology)
- Dietary Supplements
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Endothelium, Vascular
(drug effects, physiopathology)
- Female
- Follow-Up Studies
- Humans
- Male
- Radioimmunoassay
- Time Factors
- Treatment Outcome
- Ultrasonography
- Vasodilation
(drug effects, physiology)
- Vitamin D
(administration & dosage, analogs & derivatives, blood)
- Vitamin D Deficiency
(blood, drug therapy, physiopathology)
- Vitamins
(administration & dosage)
|